These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18240418)

  • 21. Natural history of hepatocellular carcinoma and current treatment options.
    Raoul JL
    Semin Nucl Med; 2008 Mar; 38(2):S13-8. PubMed ID: 18243838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune hepatitis: the way we were, the way we are today and the way we hope to be.
    Mackay IR; Toh BH
    Autoimmunity; 2002 Aug; 35(5):293-305. PubMed ID: 12515283
    [No Abstract]   [Full Text] [Related]  

  • 23. Current status of experimental chemical carcinogenesis and its applications to human cancer risk.
    Lijinsky W
    Cancer Res; 1979 Jul; 39(7 Pt 2):2887-90. PubMed ID: 376127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The history and future of chemical carcinogenesis.
    Boyland E
    Br Med Bull; 1980 Jan; 36(1):5-10. PubMed ID: 7020830
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hepatitis B virus surface antigen (HBSAG) and primary liver carcinoma: a retrospective study].
    Sarno EN; Vieira LM; Faulhaber DM
    Rev Inst Med Trop Sao Paulo; 1980; 22(1):20-3. PubMed ID: 6254134
    [No Abstract]   [Full Text] [Related]  

  • 26. Liver cell cancer: insights into the pathogenesis of hepatocellular carcinoma in humans from experimental hepatocarcinogenesis in the rat.
    Farber E
    Monogr Pathol; 1987; (28):199-222. PubMed ID: 3023976
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hepatocellular carcinoma in the non-cirrhotic liver: renewed interest].
    Bernard PH; Blanc JF; Le Bail B; de Ledinghen V; Rullier A; Balabaud C; Bioulac-Sage P
    Gastroenterol Clin Biol; 1998 Apr; 22(4):371-4. PubMed ID: 9762265
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of epithelial cell cultures for studies on the mechanism of transformation by chemical carcinogens.
    Weinstein IB; Yamaguchi N; Gebert R; Kaighn ME
    In Vitro; 1975; 11(3):130-41. PubMed ID: 170195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver-cell dysplasia and hepatocellular carcinoma.
    Podda M; Roncalli M; Battezzati PM; Borzio M; Bruno S; Servida E; Coggi G
    Ital J Gastroenterol; 1992 Jan; 24(1):39-42. PubMed ID: 1315175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatocellular carcinoma and type B hepatitis.
    Hadziyannis SJ
    Clin Gastroenterol; 1980 Jan; 9(1):117-34. PubMed ID: 6249525
    [No Abstract]   [Full Text] [Related]  

  • 31. History of cancer investigation.
    Gómez P; Rosado A
    Arch Invest Med (Mex); 1981; 12(3):361-75. PubMed ID: 7027985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. History of chemical carcinogenesis: some prospective remarks.
    Shimkin MB; Triolo VA
    Prog Exp Tumor Res; 1969; 11():1-20. PubMed ID: 4890070
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hepatocellular carcinoma].
    Andersen IB; Sørensen TI; Krogsgaard K
    Ugeskr Laeger; 1989 Feb; 151(9):550-3. PubMed ID: 2538017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of alcohol in liver carcinogenesis.
    McKillop IH; Schrum LW
    Semin Liver Dis; 2009 May; 29(2):222-32. PubMed ID: 19387921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypercarcinogenic state].
    Hino O
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():45-9. PubMed ID: 11761991
    [No Abstract]   [Full Text] [Related]  

  • 36. [Primary and secondary prevention of HBV-related hepatocellular carcinoma by antiviral treatment].
    Hosaka T
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():559-64. PubMed ID: 26845997
    [No Abstract]   [Full Text] [Related]  

  • 37. Membranous obstruction of the inferior vena cava: etiology and relation to hepatocellular carcinoma.
    Okuda K
    Gastroenterology; 1982 Feb; 82(2):376-9. PubMed ID: 6274733
    [No Abstract]   [Full Text] [Related]  

  • 38. [Risk of liver cancer due to peanut butter?].
    Nguyen HN
    Dtsch Med Wochenschr; 1999 Mar; 124(10):299. PubMed ID: 10191826
    [No Abstract]   [Full Text] [Related]  

  • 39. Some historical aspects of N-aryl carcinogens and their metabolic activation.
    Miller JA; Miller EC
    Environ Health Perspect; 1983 Mar; 49():3-12. PubMed ID: 6339227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aflatoxin as a human carcinogen.
    Wogan GN
    Hepatology; 1999 Aug; 30(2):573-5. PubMed ID: 10421671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.